Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-09 12:39 pm Purchase | 13G | Terns Pharmaceuticals Inc. TERN | FMR LLC | 7,378,641 14.901% | 1,736,567 (+30.78%) | View |
| 2023-02-09 06:15 am Sale | 13G | Terns Pharmaceuticals Inc. TERN | Auspice Ltd | 941,206 1.96% | -470,000 (-33.30%) | View |
| 2023-02-08 5:24 pm Unchanged | 13G | Terns Pharmaceuticals Inc. TERN | BML Investment Partners L.P. | 0 0% | 0 (Unchanged) | View |
| 2023-02-08 5:23 pm Sale | 13G | Terns Pharmaceuticals Inc. TERN | BML Investment Partners L.P. | 0 0% | -1,764,274 (Position Closed) | View |
| 2023-02-06 2:45 pm Sale | 13G | Terns Pharmaceuticals Inc. TERN | LAV Biosciences Fund V L.P. | 2,901,566 6.1% | -63,304 (-2.14%) | View |
| 2023-01-03 4:58 pm Purchase | 13G | Terns Pharmaceuticals Inc. TERN | SUVRETTA CAPITAL MANAGEMENT LLC | 3,448,275 7% | 3,448,275 (New Position) | View |
| 2022-12-29 2:57 pm Sale | 13G | Terns Pharmaceuticals Inc. TERN | LAV Biosciences Fund V L.P. | 2,964,870 6.18% | -1,816,696 (-37.99%) | View |
| 2022-12-28 5:14 pm Purchase | 13D | Terns Pharmaceuticals Inc. TERN | ORBIMED ADVISORS LLC | 7,619,135 15.4% | 137,931 (+1.84%) | View |
| 2022-12-23 3:35 pm Purchase | 13G | Terns Pharmaceuticals Inc. TERN | Flynn James E | 2,851,287 5.94% | 991,287 (+53.30%) | View |
| 2022-12-12 08:41 am Purchase | 13G | Terns Pharmaceuticals Inc. TERN | FMR LLC | 5,642,074 14.999% | 5,539,780 (+5415.55%) | View |
| 2022-08-26 7:24 pm Purchase | 13G | Terns Pharmaceuticals Inc. TERN | Venrock Healthcare Capital Partners III L.P. | 3,066,241 8.2% | 3,066,241 (New Position) | View |
| 2022-08-25 09:32 am Purchase | 13G | Terns Pharmaceuticals Inc. TERN | Fairmount Funds Management LLC | 2,050,000 5.45% | 2,050,000 (New Position) | View |
| 2022-08-18 4:39 pm Purchase | 13D | Terns Pharmaceuticals Inc. TERN | ORBIMED ADVISORS LLC | 7,481,204 19.9% | 3,690,000 (+97.33%) | View |
| 2022-08-16 5:20 pm Sale | 13G | Terns Pharmaceuticals Inc. TERN | Flynn James E | 1,860,000 4.94% | -485,959 (-20.71%) | View |
| 2022-06-10 11:04 am Sale | 13G | Terns Pharmaceuticals Inc. TERN | FMR LLC | 102,294 0.404% | -2,698,691 (-96.35%) | View |
| 2022-06-07 4:41 pm Purchase | 13G | Terns Pharmaceuticals Inc. TERN | BML Investment Partners L.P. | 1,764,274 7% | 1,764,274 (New Position) | View |
| 2022-04-06 10:27 am Purchase | 13G | Terns Pharmaceuticals Inc. TERN | Auspice Ltd | 1,411,206 5.6% | 1,411,206 (New Position) | View |
| 2022-02-11 4:15 pm Sale | 13G | Terns Pharmaceuticals Inc. TERN | Flynn James E | 2,345,959 9.28% | -36,074 (-1.51%) | View |
| 2022-02-09 12:29 pm Purchase | 13G | Terns Pharmaceuticals Inc. TERN | LAV Biosciences Fund V L.P. | 4,781,566 18.9% | 4,781,566 (New Position) | View |
| 2022-02-09 10:01 am Sale | 13G | Terns Pharmaceuticals Inc. TERN | FMR LLC | 2,800,985 11.085% | -86,753 (-3.00%) | View |